Ignite Creation Date:
2025-12-18 @ 9:07 AM
Ignite Modification Date:
2025-12-18 @ 9:07 AM
Study NCT ID:
NCT03497949
Status:
None
Last Update Posted:
2018-04-17 00:00:00
First Post:
2018-04-10 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Peri-operative Vasopressor Support in Patients Operated for an Acute Hip Fracture (AHF)
Sponsor:
None
Organization:
Study Overview
Official Title:
Peri-operative Vasopressor Support in Patients Operated for an Acute Hip Fracture (AHF)
Status:
None
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The incidence of hypotension perioperatively during operation of an acute hip fracture is unknown. As a surrogate factor the usage of vasopressor support is more adequate as the registration of vasopressor drugs are many times not complete in records. The investigators retrospectively investigated the anesthetic journals of 1100 patients with an acute hip fracture (AHF) noting confounding factors and the usage of vasopressors either by injections or infusions and then correlated these results to mortality at 30-, 90- and 365-days Confounding factors were; all comorbitity, age, ASA grade as well as type of anesthesia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: